Announce Date | 04/25/2025 |
EPS Normalized Actual | $0.72 (Miss by $-0.015) |
EPS GAAP Actual | $0.72 (Miss by $-0.015) |
Revenue Actual | $8.49B |
Revenue Surprise | Beat by $8490M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 4.1874 | 8.07 | 3.93278 | 4.50572 | 1 |
Dec 2028 | 5.81 | 5.82 | 5.29244 | 6.07143 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.58 | 0.58 | 8.49B | -2.56% | 8490M |
FQ4 2024 (Dec 2024) | 0.77 | 0.77 | 9.284B | 3.17% | 9284M |
FQ3 2024 (Sep 2024) | 0.84 | 0.84 | 9.159B | 9.27% | 9159M |
FQ2 2024 (Jun 2024) | 0.78 | 0.78 | 9.139B | 11.38% | 9139M |
FQ1 2024 (Mar 2024) | 0.75 | 0.75 | 8.707B | 11.15% | 8707M |
FQ4 2023 (Dec 2023) | 0 | 0 | 8.99B | 12.36% | 8990M |
FQ3 2023 (Sep 2023) | 0.79 | 0.79 | 8.31B | 10.02% | 8310M |
FQ2 2023 (Jun 2023) | 0.73 | 0.73 | 8.099B | 16.37% | 8099M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Dec 2029) | 1.0974 | -- | 1.05715 | 1.17444 | 2 |
FQ3 2029 (Sep 2029) | 1.3294 | -- | 1.23943 | 1.42535 | 5 |
FQ2 2029 (Jun 2029) | 1.2855 | -- | 1.19851 | 1.37828 | 3 |
FQ1 2029 (Mar 2029) | 1.2167 | -- | 1.13436 | 1.30451 | 3 |
FQ4 2028 (Oct 2028) | 1.283 | -- | 1.283 | 1.283 | 9 |
FQ3 2028 (Jul 2028) | 1.2365 | -- | 1.2365 | 1.2365 | 12 |
FQ2 2028 (Jun 2028) | 1.2365 | -- | 1.2365 | 1.2365 | 11 |
FQ1 2028 (Mar 2028) | 1.177 | -- | 1.177 | 1.177 | 17 |
FQ4 2027 (Oct 2027) | 1.2046 | -- | 1.2046 | 1.2046 | 13 |
FQ3 2027 (Jul 2027) | 1.1637 | -- | 1.1637 | 1.1637 | 8 |
FQ2 2027 (Jun 2027) | 1.1637 | -- | 1.1637 | 1.1637 | 8 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Dec 2029) | 10.34B | -- | 10.04B | 10.89B | 2 |
FQ3 2029 (Sep 2029) | 10.28B | -- | 9.74B | 10.85B | 4 |
FQ2 2029 (Jun 2029) | 10.22B | -- | 9.69B | 10.79B | 5 |
FQ1 2029 (Mar 2029) | 10.16B | -- | 9.63B | 10.72B | 4 |
FQ4 2028 (Oct 2028) | 9.66B | -- | 9.66B | 9.66B | 6 |
FQ3 2028 (Jul 2028) | 9.61B | -- | 9.61B | 9.61B | 6 |
FQ2 2028 (Jun 2028) | 10.02B | -- | 10.02B | 10.02B | 13 |
FQ1 2028 (Mar 2028) | 9.96B | -- | 9.96B | 9.96B | 13 |
FQ4 2027 (Oct 2027) | 9.44B | -- | 9.44B | 9.44B | 7 |
FQ3 2027 (Jul 2027) | 9.39B | -- | 9.39B | 9.39B | 7 |
FQ2 2027 (Jun 2027) | 9.79B | -- | 9.79B | 9.79B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.58 | 0.58 | 100% | |
FQ4 2024 (Dec 2024) | 0.77 | 0.77 | 100% | |
FQ3 2024 (Sep 2024) | 0.84 | 0.84 | 100% | |
FQ2 2024 (Jun 2024) | 0.78 | 0.78 | 100% | |
FQ1 2024 (Mar 2024) | 0.75 | 0.75 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 0.79 | 0.79 | 100% | |
FQ2 2023 (Jun 2023) | 0.73 | 0.73 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $8.49B | $8490M | 100% |
FQ4 2024 (Dec 2024) | $0B | $9.28B | $9284M | 100% |
FQ3 2024 (Sep 2024) | $0B | $9.16B | $9159M | 100% |
FQ2 2024 (Jun 2024) | $0B | $9.14B | $9139M | 100% |
FQ1 2024 (Mar 2024) | $0B | $8.71B | $8707M | 100% |
FQ4 2023 (Dec 2023) | $0B | $8.99B | $8990M | 100% |
FQ3 2023 (Sep 2023) | $0B | $8.31B | $8310M | 100% |
FQ2 2023 (Jun 2023) | $0B | $8.1B | $8099M | 100% |